These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 38816411)
1. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma. Li S; Liu Z; Chen Q; Chen Y; Ji S Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411 [TBL] [Abstract][Full Text] [Related]
2. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma. Zhang J; Ling X; Fang C; Ma J Cell Mol Biol Lett; 2022 May; 27(1):39. PubMed ID: 35578166 [TBL] [Abstract][Full Text] [Related]
4. A Novel Clinical Six-Flavoprotein-Gene Signature Predicts Prognosis in Esophageal Squamous Cell Carcinoma. Peng L; Guo JC; Long L; Pan F; Zhao JM; Xu LY; Li EM Biomed Res Int; 2019; 2019():3869825. PubMed ID: 31815134 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
6. A novel mitochondrial metabolism-related gene signature for predicting the prognosis of oesophageal squamous cell carcinoma. Lin W; Ye C; Sun L; Chen Z; Qu C; Zhu M; Li J; Kong R; Xu Z Aging (Albany NY); 2024 Jun; 16(11):9649-9679. PubMed ID: 38843392 [TBL] [Abstract][Full Text] [Related]
7. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma. Ma C; Luo H Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781 [TBL] [Abstract][Full Text] [Related]
8. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma. Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma. Li X; Xiao X; Chang R; Zhang C J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983 [TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma. Zhu J; Zhao Y; Wu G; Zhang X; Chen Q; Yang B; Guo X; Ji S; Gu K Oxid Med Cell Longev; 2022; 2022():7465880. PubMed ID: 35903713 [TBL] [Abstract][Full Text] [Related]
11. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics. Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264 [TBL] [Abstract][Full Text] [Related]
12. Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma. Shi X; Li Y; Pan S; Liu X; Ke Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H Sci Rep; 2022 Feb; 12(1):1960. PubMed ID: 35121801 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics Analysis Reveals a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma. Yang H; Chen Y; Huang X; Gu Y; Chen Z; Mao W Int J Med Sci; 2024; 21(7):1213-1226. PubMed ID: 38818465 [No Abstract] [Full Text] [Related]
14. Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer. Yu Y; Li Z; Huang C; Fang H; Zhao F; Zhou Y; Pan X; Li Q; Zhuang Y; Chen L; Xu J; Wang W Cancer Med; 2020 Jan; 9(2):575-585. PubMed ID: 31793228 [TBL] [Abstract][Full Text] [Related]
15. A six-microRNA risk score model predicts prognosis in esophageal squamous cell carcinoma. Mao Y; Fu Z; Zhang Y; Dong L; Zhang Y; Zhang Q; Li X; Wang C J Cell Physiol; 2019 May; 234(5):6810-6819. PubMed ID: 30387125 [TBL] [Abstract][Full Text] [Related]
16. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration. Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454 [TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y Front Oncol; 2021; 11():769727. PubMed ID: 34926275 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma. Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127 [TBL] [Abstract][Full Text] [Related]
19. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer. Zhang Z; Wang J; Han W; Zhao L BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402 [TBL] [Abstract][Full Text] [Related]
20. A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis. Zhan XH; Jiao JW; Zhang HF; Li CQ; Zhao JM; Liao LD; Wu JY; Wu BL; Wu ZY; Wang SH; Du ZP; Shen JH; Zou HY; Neufeld G; Xu LY; Li EM Cancer Med; 2017 Jul; 6(7):1707-1719. PubMed ID: 28556501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]